These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8389196)

  • 1. The site of action of pantoprazole in the gastric H+/K(+)-ATPase.
    Shin JM; Besancon M; Simon A; Sachs G
    Biochim Biophys Acta; 1993 Jun; 1148(2):223-33. PubMed ID: 8389196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.
    Besancon M; Simon A; Sachs G; Shin JM
    J Biol Chem; 1997 Sep; 272(36):22438-46. PubMed ID: 9278394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane topology and omeprazole labeling of the gastric H+,K(+)-adenosinetriphosphatase.
    Besancon M; Shin JM; Mercier F; Munson K; Miller M; Hersey S; Sachs G
    Biochemistry; 1993 Mar; 32(9):2345-55. PubMed ID: 8382947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole.
    Nishioka K; Nagao T; Urushidani T
    Biochem Pharmacol; 1999 Oct; 58(8):1349-59. PubMed ID: 10487539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural aspects of the gastric H,K ATPase.
    Shin JM; Besancon M; Bamberg K; Sachs G
    Ann N Y Acad Sci; 1997 Nov; 834():65-76. PubMed ID: 9405786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo.
    Shin JM; Sachs G
    Biochem Pharmacol; 2004 Dec; 68(11):2117-27. PubMed ID: 15498502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of the gastric H+,K(+)-ATPase by omeprazole and related compounds.
    Lorentzon P; Bayati A; Lee H; Andersson K
    Ann N Y Acad Sci; 1997 Nov; 834():592-9. PubMed ID: 9405870
    [No Abstract]   [Full Text] [Related]  

  • 8. Pantoprazole: a novel H+/K(+)-ATPase inhibitor with an improved pH stability.
    Beil W; Staar U; Sewing KF
    Eur J Pharmacol; 1992 Aug; 218(2-3):265-71. PubMed ID: 1330598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuing development of acid pump inhibitors: site of action of pantoprazole.
    Shin JM; Besancon M; Prinz C; Simon A; Sachs G
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():11-23. PubMed ID: 7514042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor.
    Simon WA; Keeling DJ; Laing SM; Fallowfield C; Taylor AG
    Biochem Pharmacol; 1990 Jun; 39(11):1799-806. PubMed ID: 2160820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: the continuing development of proton pump inhibitors with particular reference to pantoprazole.
    Huber R; Kohl B; Sachs G; Senn-Bilfinger J; Simon WA; Sturm E
    Aliment Pharmacol Ther; 1995 Aug; 9(4):363-78. PubMed ID: 8527612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of acid secretion following treatment with proton pump inhibitors.
    Shin JM; Sachs G
    Gastroenterology; 2002 Nov; 123(5):1588-97. PubMed ID: 12404233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proton pump inhibitor, E3810, binds to the N-terminal half of the alpha-subunit of gastric H+,K(+)-ATPase.
    Morii M; Hamatani K; Takeguchi N
    Biochem Pharmacol; 1995 Jun; 49(12):1729-34. PubMed ID: 7598734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The basis of differentiation of PPIs.
    Sachs G; Shin JM
    Drugs Today (Barc); 2004 Mar; 40 Suppl A():9-14. PubMed ID: 15190382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric acid secretion: activation and inhibition.
    Sachs G; Prinz C; Loo D; Bamberg K; Besancon M; Shin JM
    Yale J Biol Med; 1994; 67(3-4):81-95. PubMed ID: 7502535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topology and sites in the H,K-ATPase.
    Sachs G; Shin JM; Besancon M; Munson K; Hersey S
    Ann N Y Acad Sci; 1992 Nov; 671():204-16. PubMed ID: 1337673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacology of the gastric acid pump: the H+,K+ ATPase.
    Sachs G; Shin JM; Briving C; Wallmark B; Hersey S
    Annu Rev Pharmacol Toxicol; 1995; 35():277-305. PubMed ID: 7598495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural aspects of the gastric H,K-ATPase.
    Sachs G; Besancon M; Shin JM; Mercier F; Munson K; Hersey S
    J Bioenerg Biomembr; 1992 Jun; 24(3):301-8. PubMed ID: 1383197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (H+,K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 4. A novel series of dimethoxypyridyl-substituted inhibitors with enhanced selectivity. The selection of pantoprazole as a clinical candidate.
    Kohl B; Sturm E; Senn-Bilfinger J; Simon WA; Krüger U; Schaefer H; Rainer G; Figala V; Klemm K
    J Med Chem; 1992 Mar; 35(6):1049-57. PubMed ID: 1313110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The H+, K(+)-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole.
    Simon WA; Büdingen C; Fahr S; Kinder B; Koske M
    Biochem Pharmacol; 1991 Jul; 42(2):347-55. PubMed ID: 1650212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.